Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons

Background. Antiretroviral preexposure prophylaxis (PrEP), using daily oral combination tenofovir disoproxil fumarate plus emtricitabine, is an effective human immunodeficiency virus (HIV) prevention strategy for populations at high risk of HIV acquisition. Although the primary mode of action for th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Infect Dis
Egile Nagusiak: Pattacini, Laura, Murnane, Pamela M., Baeten, Jared M., Fluharty, Tayler R., Thomas, Katherine K., Bukusi, Elizabeth, Katabira, Elly, Mugo, Nelly, Donnell, Deborah, Lingappa, Jairam R., Celum, Connie, Marzinke, Mark, McElrath, M. Juliana, Lund, Jennifer M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2015
Gaiak:
Major Articles and Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4836720/
https://ncbi.nlm.nih.gov/pubmed/25520426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu815
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak